ALT heads into a high-stakes 2026 as pemvidutide drives key phase III and mid-stage catalysts that could reshape its ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health ...

Early results from a pilot study show the minimally invasive endoscopic intervention reduces the weight gain that occurs ...

D&D Pharmatech, a company specializing in the development of GLP-1 (glucagon-like peptide-1) class novel drugs, announced on April 22 that it has ...

The traditional media buying-selling model — built on manual negotiation and personal relationships — is being challenged by ...

Bottled at 116.4 proof, the 2026 release blends two mash bills and includes whiskies aged 7 to 8 years.

People of Note has a pleasant music-themed twist on turn-based gameplay. By Harold Goldberg In the pun-filled People of Note, ...

If you're looking for a ready-to-eat meal for a weeknight dinner, Costco's deli has brought out a new sous vide beef dinner ...

MLB player prop bets and odds for Elly De La Cruz on Wednesday, April 22, 2026, as the Cincinnati Reds take on the Tampa Bay ...

Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced the pricing of its previously announced ...

The American Lung Association listed Bucks County as one of five in Pennsylvania receiving a failing grade for certain air ...